Vol. 31 (2) 2024
The burden of HCV among prevalent hemodialysis patients after the National Egyptian HCV Eradication program The Egyptian Journal of Immunology Volume 31 (2), April, 2024 Pages: 112 – 121. www.Ejimmunology.org https://doi.org/10.55133/eji.310212 Iman I. Sarhan1, Magdy...
Vol. 31 (2) 2024
Serum microRNA-16 as a potential biomarker for HCV-induced hepato-cellular carcinoma in Egyptian patients The Egyptian Journal of Immunology Volume 31 (2), April, 2024 Pages: 102 – 111. www.Ejimmunology.org https://doi.org/10.55133/eji.310211 Amr T. El Hawary1, Fedaa...
Vol. 31 (2) 2024
The role of C-reactive protein, procalcitonin, interleukin-6 and neutrophil / lymphocyte ratio as a laboratory biomarker in COVID-19 The Egyptian Journal of Immunology Volume 31 (2), April, 2024 Pages: 93 – 101. www.Ejimmunology.org https://doi.org/10.55133/eji.310210...
Vol. 31 (2) 2024
Association between estrogen receptor alpha and aryl hydrocarbon receptor gene polymorphisms in the prognosis of breast cancer in Egypt The Egyptian Journal of Immunology Volume 31 (2), April, 2024 Pages: 87 – 92. www.Ejimmunology.org...
Vol. 31 (2) 2024
Influence of climate change on emerging pathogens and human immunity The Egyptian Journal of Immunology Volume 31 (2), April, 2024 Pages: 71 – 86. www.Ejimmunology.org https://doi.org/10.55133/eji.310208 Amira El-Far1, Noha Yousry1, Faten Abouelmagd2,3, Mohamed E....
Vol. 31 (2) 2024
Association of serum IL-30 and soluble GP130 with the risk of psoriasis vulgaris The Egyptian Journal of Immunology Volume 31 (2), April, 2024 Pages: 61 – 70. www.Ejimmunology.org https://doi.org/10.55133/eji.310207 Rofaida R. Shehata1, Sara A. Atta2, Abd-Elsamea S....
